An Act to Establish Additional Requirements for Dentists to
Maine Legislature, Session 132, LD 1374
Sponsors: BALDACCI
Amends: 32 MRSA §18302, 32 MRSA §18371, 32 MRSA §18395

Legislative Document
No. 1374
S.P. 568
In Senate, April 1, 2025
An Act to Establish Additional Requirements for Dentists to 
Administer Botulinum Toxin and Dermal Fillers
Received by the Secretary of the Senate on March 28, 2025.  Referred to the Committee on 
Health Coverage, Insurance and Financial Services pursuant to Joint Rule 308.2 and ordered 
printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator BALDACCI of Penobscot.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  32 MRSA §18302, sub-§1-A is enacted to read:
1-A.  Botulinum toxin.  "Botulinum toxin" means a neurotoxic protein produced by 
the bacterium Clostridium botulinum and related species used for various medical and other 
purposes, including treating muscle spasms, wrinkles and excessive sweating. 
Sec. 2.  32 MRSA §18302, sub-§17-A is enacted to read:
17-A.  Dermal filler.  "Dermal filler" means a gel-like substance that is injected 
beneath the skin to restore lost volume, smooth lines or soften creases on the face or 
enhance facial contours.
Sec. 3.  32 MRSA §18371, sub-§1, ¶O, as corrected by RR 2021, c. 1, Pt. A, §35, 
is amended to read:
O.  Administer botulinum toxin or dermal fillers to a patient with a diagnosed dental 
condition or when that administration is identified as part of a patient's dental treatment 
plan.  A dentist who has successfully completed postgraduate training and certification 
in oral and maxillofacial surgery from a program accredited by the American Dental 
Association Commission on Dental Accreditation or its successor organization and 
who has met the requirements of section 18395 may administer botulinum toxin or 
dermal fillers in the course of treatment for oral or maxillofacial disease, disfigurement 
or disjunction.
Sec. 4.  32 MRSA §18395 is enacted to read:
§18395. Botulinum toxin or dermal fillers
1. Botulinum toxin or dermal fillers. A dentist may administer botulinum toxin or a 
dermal filler for a diagnosed dental condition or as part of a patient's dental treatment 
pursuant to this section and section 18371, subsection 1, paragraph O. 
2. Additional requirements to administer botulinum toxin or dermal fillers.  In 
addition to the requirements of section 18371, subsection 1, paragraph O, a dentist may 
administer botulinum toxin or a dermal filler if the dentist has completed training accredited 
by the American Dental Association's program for continuing education recognition, the 
Academy of General Dentistry's program approval for continuing education or another 
nationally recognized and accredited training program approved by the board. 
A. For botulinum toxin, the dentist must have completed a minimum of 8 hours of 
training in the administration of botulinum toxin that includes instruction in the 
anatomy of the head and neck, neurophysiology, patient selection, pharmacological 
effects and contraindications, management of complications and informed consent 
requirements and hands-on training in the administration of botulinum toxin. 
B. For a dermal filler, the dentist must have completed a minimum of 8 hours of 
training in the administration of a dermal filler that includes instruction in the anatomy 
of the head and neck, neurophysiology, patient selection, pharmacological effects and 
contraindications, management of complications and informed consent requirements 
and hands-on training in the administration of a dermal filler. 
3. Administration of botulinum toxin or dermal fillers.  Prior to administering 
botulinum toxin or a dermal filler, a dentist shall:
A. Obtain the patient's medical and dental history; 
B. Perform a clinical examination; and 
C. Obtain the informed consent of the patient. 
SUMMARY
This bill adds additional requirements for dentists to administer botulinum toxin or 
dermal fillers to patients.